arginine glutamate has been researched along with Retinal Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afzal, A; Caballero, S; Gallego, E; Grant, MB; Li Calzi, S; Li, N; Neu, J; Pan, H; Shaw, LC; Spoerri, PE | 1 |
1 other study(ies) available for arginine glutamate and Retinal Neovascularization
Article | Year |
---|---|
The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Cells, Cultured; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant, Newborn; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Oxygen; Pigment Epithelium of Eye; Pregnancy; Retinal Neovascularization; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2006 |